Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

3 very large randomized trials have recently announced their results, massively expanding the evidence base for the efficacy and safety of intensive glycemic control in patients with type 2 diabetes. Taken together, these trials indicate that tight glycemic control is potentially harmful (one of the trials was stopped earlier than planned because of an increased risk of death in patients assigned to the intensive glycemic control arm) while offering potential benefits of unclear importance to patients. In this commentary, we review these trials, their methods, results, and implications for practice. We finish by formulating a recommended approach to the contemporary evidence-based management of patients with type 2 diabetes. Copyright by Medycyna Praktyczna, Kraków 2008.

Original languageEnglish (US)
Pages (from-to)502-507
Number of pages6
JournalPolskie Archiwum Medycyny Wewnetrznej
Volume118
Issue number9
DOIs
StatePublished - 2008

Keywords

  • Diabetes complications
  • Diabetes treatment
  • Evidence-based medicine
  • Glycemic control
  • Randomized trials

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?'. Together they form a unique fingerprint.

  • Cite this